Rob Michiels

Rob Michiels was elected as chairman of the Company's Board of Directors in 2016. He is a 30+-year veteran of the US medical device industry, both in corporate positions and as a serial start-up entrepreneur. He most recently served as CEO of CardiAQ™ Valve Technologies, a venture-funded start-up developing transcatheter mitral valve implantation that was acquired by Edwards Lifesciences in 2015. He previously served as president and COO of CoreValve and as president and COO of InterVentional Technologies. He helped develop both companies from cardiovascular start-ups into established market leaders creating and marketing new and innovative interventional technologies that have strong synergies with the FEops story. Rob is also a founding partner of CONSILIUM Associates, a medical device market research company active in identifying, funding and greenhousing start-up technologies. Fluent in English, French and Dutch, he holds a bachelor's degree in economics from Antwerp University in Belgium and an MBA from Indiana University.